Wei Shen has a diverse background in investment and corporate governance, currently serving as a board member for multiple organizations including Full-Life Technologies, Allotex, Worgpharma, Cellics Therapeutics, Cello Therapeutics, Corsair Pharma, AccuraGen, WallabyPhenox, and BridGene Biosciences. Wei's previous experience includes significant roles at China Renaissance in the M&A Group, Junson Capital as Investment Director and Head of Principal Investment, and Lincoln International as an Investment Banking Analyst. Wei has also gained valuable expertise in risk assurance during an internship at PwC. Wei holds a Bachelor's Degree from Indiana University - Kelley School of Business and an MBA from The University of Chicago Booth School of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices